Litcius/Paper detail

FDA approves Merck & Co’s pulmonary arterial hypertension drug sotatercept

Katie Kingwell

2024Nature Reviews Drug Discovery15 citationsDOI

Topics & Concepts

MedicineDrugPulmonary hypertensionPharmacologyCardiologyInternal medicinePulmonary Hypertension Research and TreatmentsScience, Research, and Medicine
FDA approves Merck & Co’s pulmonary arterial hypertension drug sotatercept | Litcius